Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIR Inhaled Insulin vs Glargine in Type 2 Diabetes
NCT00355849Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2006
- Primary completion
- Jun 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 12
01
Overview
A Phase 3 trial of AIR Inhaled Insulin in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Aug 2006; status: completed.
02
Drugs
AIR Inhaled Insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00355849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355849.